Accessibility Menu
CompuMed logo

CompuMed(OTC) CMPD

Market Cap$7.74MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)+30%
5 Year+7%
1 Year+62%
1 Month+0%
$6.00
-7.69%
-0.50Today
CompuMed last closing stock price
MetricPriceDate
Last closeUSD 6.002026-07-29
CompuMed stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.45%USD 6.702026-07-22
1 month+0%USD 6.002026-06-29
3 month-3.47%USD 6.222026-04-30
Year to date+36.13%USD 4.412025-12-31
1 year+62.16%USD 3.702025-07-28
3 year+169.06%USD 2.232023-07-28
5 year+7.05%USD 5.612021-07-30
Since inception+30%USD 5.001990-08-21

CompuMed Financials at a Glance

Market Cap

$7.74MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$8.14M

Net Income (TTM)

-$253.98K

EPS (TTM)

-$0.20

P/E Ratio

-30.67

Dividend

$0.00

Beta (Volatility)

0.28 (Low)

Price

$6.00

Volume

640

Open

$6.05

Previous Close

$6.00

Daily Range

$6.00 - $6.05

52-Week Range

$1.95 - $6.95

Estimated Earnings Date

Feb 9, 2026

CMPD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CompuMed

CompuMed, Inc. is a provider of advanced telemedicine solutions, focusing on telecardiology and teleradiology services. The company connects healthcare institutions with U.S. Board-Certified specialists through cloud-based platforms, enhancing clinical care for patients globally.

Products and Services
  • Telecardiology services including ECG and echocardiogram interpretations
  • Teleradiology services offering expert image analysis and reporting
  • OsteoGram software for osteoporosis management and mobile ECG solutions
Growth Outlook
  • Revenue of $2.03 million in the latest quarter, showing consistent demand
  • Strong gross profit margin of 48% indicates effective cost management
  • Positive cash flow from operations of $249,134 in the latest quarter
Financial Highlights
  • Trailing twelve months (TTM) revenue of $8.4 million reflects steady growth
  • Current ratio of 2.37 suggests strong liquidity position
  • Net income of -$83,043 in the latest quarter shows potential for recovery
CompuMed, Inc. operates in the healthcare information services sector, providing essential telemedicine solutions that cater to a diverse clientele, including rural healthcare providers and correctional facilities. The company's focus on telecardiology and teleradiology positions it well within the growing telehealth market, which has seen increased adoption due to the demand for remote healthcare services. Recent financial performance indicates a solid revenue stream, with a gross profit margin that highlights effective operational efficiency. The current ratio suggests that CompuMed maintains a healthy liquidity position, which is crucial for sustaining operations and funding future growth initiatives. Despite reporting a net loss in the latest quarter, the positive cash flow from operations indicates that the company is generating cash, which can be reinvested into its services and technology. Overall, CompuMed, Inc. presents an intriguing opportunity for investors interested in the telemedicine sector, particularly as healthcare continues to evolve towards more remote and accessible solutions.
AI Generated • Jul 17, 2026

Industry

Health Care Technology

Sector

Health Care

CEO

Lee D. Keddie

Website

www.compumedinc.com

Headquarters

Los Angeles, CA 90045, US

CMPD Financials

Key Financial Metrics (TTM)

Gross Margin

47.73%

Operating Margin

-2.47%

Net Income Margin

-3.12%

Return on Equity

-8.06%

Return on Capital

-0.44%

Return on Assets

-5.57%

Earnings Yield

-3.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.74MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.29M

Volume

640

Avg. Volume

641.436

Financials (TTM)

Gross Profit

$3.89M

Operating Income

-$200.84K

EBITDA

$610.31K

Operating Cash Flow

$812.75K

Capital Expenditure

-$396.29K

Free Cash Flow

$416.46K

Cash & ST Invst.

$1.47M

Total Debt

$603.07K

CompuMed Performance Analysis

CompuMed annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 6,365,2640.8%
20232023-09-30USD 5,838,109-8.3%
20242024-09-30USD 6,222,0186.6%
20252025-09-30USD 7,546,20121.3%
CompuMed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-306.3%
Q42025-09-302.2%
Q12025-12-313.5%
Q22026-03-31-3.2%
CompuMed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD 0.30-56.9%
20232023-09-30USD -0.02N/A
20242024-09-30USD 0.15N/A
20252025-09-30USD -0.05N/A
CompuMed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-14.4%
Q42025-09-30-494.7%
Q12025-12-3186.8%
Q22026-03-31-225.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.03M

+8.8%

Gross Profit

$976.38K

+15.2%

Gross Margin

48.07%

N/A

Market Cap

$7.74MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$967.34K

N/A

Employees

8

N/A

Net Income

-$83.04K

-241.7%

EBITDA

$139.57K

-53.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.47M

+3.9%

Total Debt

$603.07K

-28.6%

Accounts Receivable

$1.05M

-9.5%

Inventory

$37.71K

-78.6%

Long Term Debt

$365.81K

-39.3%

Short Term Debt

$237.26K

-1.6%

Return on Assets

-5.57%

N/A

Return on Invested Capital

-5.97%

N/A

Free Cash Flow

$224.13K

+153.6%

Operating Cash Flow

$249.13K

-22.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HLYKHealthLynked Corp.
$3.28+0.00%
CPMVMosaic ImmunoEngineering Inc.
$0.55+0.00%
RSCFReflect Scientific, Inc.
$0.04+0.00%
TDSGFTelo Genomics Corp.
$0.03-3.13%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
NOKNokia
$8.41-0.06%
SKHYSK Hynix
$126.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About CMPD

What is the current price of CompuMed?

CompuMed is trading at $6.00 per share.

What is the 52-week range for CompuMed?

Over the past 52 weeks, CompuMed has traded between $1.95 and $6.95.

How much debt does CompuMed have?

As of the most recent reporting period, CompuMed reported total debt of $603.07K.

How much cash does CompuMed have on hand?

CompuMed reported $1.47M in cash and cash equivalents in its most recent financial results.

What is CompuMed’s dividend yield?

CompuMed does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services